Genscript Biotech News

News

Ticker

1548.HK

ISIN

KYG3825B1059

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Genscript Biotech Eulerpool News

Genscript Biotech Stock News

Genscript Biotech is being monitored by journalists and investors worldwide. We gather the latest Genscript Biotech news here.

March 16·
SeekingAlpha
Genscript Biotech Corporation (GNNSF) Q4 2025 Earnings Call Transcript
March 16·
SeekingAlpha
Genscript Biotech Corporation 2025 Q4 - Results - Earnings Call Presentation
February 3·
Yahoo
Assessing Genscript Biotech (SEHK:1548) Valuation After Recent Share Price Volatility
August 18·
SeekingAlpha
Genscript Biotech Corporation (GNNSF) Q2 2025 Earnings Call Transcript
August 1·
Yahoo
GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader
July 9·
Yahoo
GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability
June 27·
Yahoo
ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy
April 23·
Yahoo
Asian Stocks Estimated Below Intrinsic Value In April 2025
March 27·
SeekingAlpha
Genscript Biotech Corporation 2024 Q4 - Results - Earnings Call Presentation
March 12·
Yahoo
GenScript Biotech Corporation Reports FY 2024 Results
December 23·
Yahoo
3 Stocks That May Be Undervalued In December 2024
December 18·
Yahoo
GenScript Announces 4th Annual Biotech Global Forum in San Francisco
November 21·
Yahoo
The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development
November 15·
Yahoo
GenScript Subsidiary ProBio Instrumental in Latest Fight Against Cancer
November 13·
Yahoo
Seasoned Marketing Executive Joins GenScript as Chief Marketing Officer
November 11·
Yahoo
GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia
October 10·
Yahoo
Genscript Biotech Corp (GNNSF) (H1 2024) Earnings Call Highlights: Robust Revenue Growth Amidst ...
August 13·
Yahoo
Health Care Roundup: Market Talk
August 12·
SeekingAlpha
GenScript Biotech Corporation (GNNSF) Q2 2024 Earnings Call Transcript
August 9·
Yahoo
GenScript Biotech Reports First Half 2024 Results

Genscript Biotech Stock Press Releases

Genscript Biotech regularly publishes news on the company's website that are relevant for investors.

February 18•
Genscript Biotech
Genscript Biotech Sees An Adjusted Loss Of Us$290.4 Million To Us$316.2 Million For Year
February 15•
Genscript Biotech
Genscript Biotech Says Legend Biotech Corp On 11 Feb Was Informed By U.S. FDA Its Phase 1 Clinical Trial For Lb1901 Has Been Placed On Clinical Hold
December 6•
Genscript Biotech
Genscript Biotech' Unit Submits NDA To Japanese Ministry Of Health, Labour And Welfare
October 22•
Genscript Biotech
Genscript Biotech Announces Cooperation On Biologic License Application Of mRna Vaccines
August 23•
Genscript Biotech
Genscript Biotech Posts HY Adjusted Net Loss Of About US$134.3 Million
May 21•
Genscript Biotech
GNS Holdings' Long Position In Genscript Biotech Increased To 8.42% On May 14 - HKEX Filing
May 14•
Genscript Biotech
Genscript Biotech To Issue 103 Mln New Shares At A Subscription Price Is HK$18.658/Share
May 14•
Genscript Biotech
Genscript Biotech Through Unit To Subscribe For Convertible Bonds In Amount Of US$70 Mln
April 30•
Genscript Biotech
Genscript Biotech Corp Says Unit Submitted Marketing Authorisation Application To European Medicines Agency For Approval Of Ciltacabtagene Autoleuce
March 26•
Genscript Biotech
Genscript Biotech Corp Posts Revenue For Year Of US$390.8 Million, Up 42.9%
February 19•
Genscript Biotech
Genscript Biotech Corp Sees An Adjusted Loss Of About US$154.5 Million To US$193.3 Million For Year
February 9•
Genscript Biotech
Genscript Biotech Says Ex-Chairman Released On Bail On Feb. 9
January 13•
Genscript Biotech
Genscript Submits Application With FDA For Use Of Cpass Sars-Cov-2 Neutralization Antibody Test In Convalescent Plasma Screening
December 21•
Genscript Biotech
Genscript Biotech Says Unit To Initiate Rolling Submission Of Biologics License Application
September 21•
Genscript Biotech
Genscript Biotech Corp Says PRC Authorities Inspected Places Of Business In Nanjing, Zhenjiang
August 2•
Genscript Biotech
Legend Biotech Announces Chief Executive Officer Transition
July 24•
Genscript Biotech
GenScript Publishes Clinical Data On Method For Detecting COVID-19 Neutralizing Antibodies In Nature Biotechnology
June 16•
Genscript Biotech
Genscript Biotech Says An Executive Director Agreed To Sell 15 Mln Shares Of Co
June 9•
Genscript Biotech
Genscript Biotech Says Wang Luquan To Sell 5 Mln Shares To Zhang Xiaolei At HK$17.32/Share
June 5•
Genscript Biotech
Genscript Biotech Updates On Separate Listing Of Legend Biotech Corp On Nasdaq Global Market
June 3•
Genscript Biotech
Genscript Files For Emergency Use Authorization Of Rapid Sars-Cov-2 Antibody Detection Kit
May 29•
Genscript Biotech
Genscript Biotech Says Legend Biotech Filed Registration Statement For IPO
May 14•
Genscript Biotech
Genscript Biotech Updates On Phase 1B/2 Cartitude-1 Study Evaluating JNJ-68284528
April 14•
Genscript Biotech
Genscript Biotech Corp Says On 11 April, Rising Arrow Enterprise Entered Purchase Agreement
March 31•
Genscript Biotech
Genscript Biotech Says Unit Sells 19.3 Million Series A Preference Shares For US$150.5 Mln
March 27•
Genscript Biotech
Genscript Biotech Corp Posts Loss For Year Us$117.5 Million
March 10•
Genscript Biotech
Genscript Biotech Submits Proposal To Stock Exchange For Spin-Off Of Cell Therapy Business
February 24•
Genscript Biotech
Genscript Biotech Corp Expect Loss Of About Us$114.0 Million To Us$144.0 Million For Year
January 15•
Genscript Biotech
Genscript And Genopis Enter Into Strategic Partnership Agreement For Manufacture Service Of GMP Plasmids

Genscript Biotech News 2026

This page contains all current news, analysis and press releases for Genscript Biotech stock (1548.HK, ISIN: KYG3825B1059). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Genscript Biotech.

Genscript Biotech Stock

Genscript Biotech GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide.